Clinical Trial Update: Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating adipose-derived mesenchymal stem cells for pulmonary arterial hypertension across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Liaocheng People's Hospital | Conditions: Pulmonary Hypertension | Phase 1, Phase 2 | Status: UNKNOWN